Popular stocks:

Rivian Automotive

TOP stocks:

Shares of other companies:

Calliditas Therapeutics (CALT) stock Forecast for 2022 – 2026

Last update: 05-28-2022, 10:42

Sector: Healthcare

The share price of Calliditas Therapeutics AB (publ) (CALT) now

What analysts predict:: $61.75

52-week high/low: $33.19 / $12.55

50/200 Day Moving Average: $17.19 / $20.59

This figure corresponds to the average price over the previous 50/200 days. For Calliditas Therapeutics stocks, the 50-day moving average is the support level today.

For Calliditas Therapeutics stocks, the 200-day moving average is the resistance level today.

Are you interested in Calliditas Therapeutics AB (publ) stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Calliditas Therapeutics stock price in 2022, 2023, 2024, 2025, 2026. How much will one Calliditas Therapeutics share be worth in 2022 - 2026?

When should I take profit in Calliditas Therapeutics stock? When should I record a loss on Calliditas Therapeutics stock? What are analysts' forecasts for Calliditas Therapeutics stock? What is the future of Calliditas Therapeutics stock?

We forecast Calliditas Therapeutics stock performance using neural networks based on historical data on Calliditas Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Calliditas Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)

The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Calliditas Therapeutics shares. This happens once a day.

Historical and forecast chart of Calliditas Therapeutics stock

The chart below shows the historical price of Calliditas Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Calliditas Therapeutics stock price can be found in the table below.

Long-term forecasts by years.

Subscribe to update forecasts!

Calliditas Therapeutics daily forecast for a month

Date	Target	Pes.	Opt.	Vol., %
May 30	18.16	17.44	18.72	7.34
May 31	17.97	17.64	18.63	5.60
Jun 01	17.20	16.71	17.85	6.79
Jun 02	16.75	16.45	17.06	3.66
Jun 03	17.30	17.13	17.76	3.69
Jun 04	17.85	17.32	18.17	4.95
Jun 05	17.70	17.05	17.96	5.35
Jun 06	17.38	16.97	17.62	3.79
Jun 07	18.23	17.83	18.63	4.50
Jun 08	17.83	17.41	18.55	6.50
Jun 09	18.14	17.78	18.52	4.13
Jun 10	18.24	17.65	18.68	5.84
Jun 11	18.86	18.23	19.10	4.76
Jun 12	19.67	18.97	20.33	7.21
Jun 13	20.28	19.84	20.80	4.85
Jun 14	20.19	19.73	20.65	4.66
Jun 15	19.92	19.21	20.70	7.72
Jun 16	19.50	18.80	19.70	4.77
Jun 17	18.89	18.13	19.37	6.82
Jun 18	18.46	17.88	18.82	5.27
Jun 19	18.90	18.71	19.64	5.00
Jun 20	18.37	17.71	19.10	7.88
Jun 21	19.14	18.80	19.48	3.67
Jun 22	19.22	18.97	19.70	3.85
Jun 23	19.37	18.83	19.64	4.32
Jun 24	18.93	18.57	19.18	3.31
Jun 25	18.68	18.34	18.96	3.36
Jun 26	18.10	17.53	18.56	5.89
Jun 27	18.13	17.47	18.42	5.45
Jun 28	17.39	16.78	17.92	6.79

Calliditas Therapeutics Daily Price Targets

Calliditas Therapeutics Stock Forecast 05-30-2022.

Forecast target price for 05-30-2022: $18.16. Positive dynamics for Calliditas Therapeutics shares will prevail with possible volatility of 6.838%.

Pessimistic target level: 17.44

Optimistic target level: 18.72

Calliditas Therapeutics Stock Forecast 05-31-2022.

Forecast target price for 05-31-2022: $17.97. Negative dynamics for Calliditas Therapeutics shares will prevail with possible volatility of 5.303%.

Pessimistic target level: 17.64

Optimistic target level: 18.63

Calliditas Therapeutics Stock Forecast 06-01-2022.

Forecast target price for 06-01-2022: $17.20. Negative dynamics for Calliditas Therapeutics shares will prevail with possible volatility of 6.361%.

Pessimistic target level: 16.71

Optimistic target level: 17.85

Calliditas Therapeutics Stock Forecast 06-02-2022.

Forecast target price for 06-02-2022: $16.75. Negative dynamics for Calliditas Therapeutics shares will prevail with possible volatility of 3.535%.

Pessimistic target level: 16.45

Optimistic target level: 17.06

Calliditas Therapeutics Stock Forecast 06-03-2022.

Forecast target price for 06-03-2022: $17.30. Positive dynamics for Calliditas Therapeutics shares will prevail with possible volatility of 3.556%.

Pessimistic target level: 17.13

Optimistic target level: 17.76

Calliditas Therapeutics Stock Forecast 06-04-2022.

Forecast target price for 06-04-2022: $17.85. Positive dynamics for Calliditas Therapeutics shares will prevail with possible volatility of 4.715%.

Pessimistic target level: 17.32

Optimistic target level: 18.17

CALT (CALT) Monthly Stock Prediction for 2022

Month	Target	Pes.	Opt.	Vol., %
Jun.	20.68	18.60	21.97	15.38
Jul.	21.90	20.61	23.89	13.76
Aug.	23.64	21.71	25.71	15.55
Sep.	21.98	20.14	24.36	17.31
Oct.	18.51	16.65	19.43	14.30
Nov.	21.19	18.61	23.93	22.21
Dec.	24.17	22.93	25.73	10.89

Full forecast for 2022

Calliditas Therapeutics forecast for this year

Calliditas Therapeutics Stock Prediction for Jun 2022

An uptrend is forecast for this month with an optimal target price of $20.6776. Pessimistic: $18.60. Optimistic: $21.97

Calliditas Therapeutics Stock Prediction for Jul 2022

An uptrend is forecast for this month with an optimal target price of $21.8955. Pessimistic: $20.61. Optimistic: $23.89

Calliditas Therapeutics Stock Prediction for Aug 2022

An uptrend is forecast for this month with an optimal target price of $23.6428. Pessimistic: $21.71. Optimistic: $25.71

Calliditas Therapeutics Stock Prediction for Sep 2022

An downtrend is forecast for this month with an optimal target price of $21.9807. Pessimistic: $20.14. Optimistic: $24.36

Calliditas Therapeutics Stock Prediction for Oct 2022

An downtrend is forecast for this month with an optimal target price of $18.5144. Pessimistic: $16.65. Optimistic: $19.43

Calliditas Therapeutics Stock Prediction for Nov 2022

An uptrend is forecast for this month with an optimal target price of $21.1878. Pessimistic: $18.61. Optimistic: $23.93

Calliditas Therapeutics Stock Prediction for Dec 2022

An uptrend is forecast for this month with an optimal target price of $24.1668. Pessimistic: $22.93. Optimistic: $25.73

Calliditas Therapeutics (CALT) Monthly Stock Prediction for 2023

Month	Target	Pes.	Opt.	Vol., %
Jan	25.91	24.09	27.49	12.36
Feb	27.09	24.93	30.49	18.23
Mar	30.90	28.14	33.66	16.40
Apr	31.72	29.01	35.58	18.46
May	30.04	25.93	33.29	22.11
Jun	29.92	26.74	33.56	20.33
Jul	35.38	30.34	37.60	19.31
Aug	33.23	29.82	34.49	13.55
Sep	33.55	28.89	36.80	21.48
Oct	33.67	30.35	35.98	15.65
Nov	32.20	27.67	35.75	22.59
Dec	37.83	32.80	40.63	19.28

Full forecast for 2023

Calliditas Therapeutics (CALT) Monthly Stock Prediction for 2024

Month	Target	Pes.	Opt.	Vol., %
Jan	31.43	28.92	33.40	13.41
Feb	33.05	29.78	37.19	19.92
Mar	30.35	28.73	33.98	15.44
Apr	30.86	29.28	32.86	10.89
May	32.57	30.83	34.05	9.45
Jun	37.76	35.90	43.14	16.80
Jul	37.55	33.77	39.05	13.52
Aug	44.61	38.42	50.29	23.60
Sep	39.19	35.39	43.13	17.95
Oct	42.09	40.17	45.85	12.38
Nov	40.09	37.20	45.73	18.66
Dec	35.90	32.97	41.29	20.15

Full forecast for 2024

Calliditas Therapeutics (CALT) Monthly Stock Prediction for 2025

Month	Target	Pes.	Opt.	Vol., %
Jan	34.47	31.78	38.27	16.94
Feb	31.91	28.76	35.73	19.51
Mar	29.73	26.12	33.57	22.21
Apr	32.16	30.20	34.48	12.40
May	29.10	26.01	33.14	21.52
Jun	34.03	32.41	38.75	16.35
Jul	33.64	30.83	37.67	18.16
Aug	33.89	31.77	38.79	18.10
Sep	33.89	32.16	37.76	14.84
Oct	37.05	31.91	42.19	24.36
Nov	35.92	30.74	41.04	25.11
Dec	37.08	34.34	39.20	12.40

Full forecast for 2025

Calliditas Therapeutics (CALT) Monthly Stock Prediction for 2026

Month	Target	Pes.	Opt.	Vol., %
Jan	35.82	31.39	37.99	17.37
Feb	36.09	33.89	39.31	13.78
Mar	38.90	35.65	42.22	15.58
Apr	36.83	32.98	40.40	18.36
May	40.75	35.10	42.37	17.17
Jun	44.15	40.71	50.53	19.43
Jul	51.12	43.64	56.17	22.31
Aug	47.82	44.45	53.99	17.67
Sep	52.27	47.70	59.72	20.12
Oct	56.24	47.80	60.51	21.01
Nov	60.30	53.08	65.57	19.05
Dec	55.14	50.12	63.00	20.46

Full forecast for 2026

Calliditas Therapeutics information and performance

Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, has focused on identifying, developing and commercializing pharmaceutical products for the treatment of orphan symptoms with an initial focus on kidney and liver diseases. The main candidate for the company’s products is Nefekon, an oral budesonide drug that is an immunosuppressive agent for the treatment of autoimmune IgA renal nephropathy. Calliditas Therapeutics AB (publ) was founded in 2004 and is headquartered in Stockholm, Sweden.

Calliditas Therapeutics Address

KUNGSBRON 1, C8, STOCKHOLM, SE

Market Capitalization: 499 821 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: - $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: None

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A

Quarterly Revenue Growth YOY: 76.95

Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 1.533

Enterprise Value (EV) /Revenue

EV To EBITDA: -

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 26586100

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A

Related stocks from Healthcare sector

Calliditas Therapeutics AB (publ) (CALT)

ImmunityBio, Inc. (IBRX)

Codex DNA, Inc. (DNAY)

Ensysce Biosciences, Inc. (ENSC)

Dicerna Pharmaceuticals, Inc. (DRNA)

Clovis Oncology, Inc. (CLVS)

Arbutus Biopharma Corp. (ABUS)

Johnson & Johnson (JNJ)

Eargo, Inc. (EAR)

DaVita Inc. (DVA)

All stock predictions

All currency forecasts

All cryptocurrency predictions

Detailed predictions for Calliditas Therapeutics stock

Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.